###begin article-title 0
Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
Vitamin D receptor (VDR) polymorphisms have been inconsistently associated with breast cancer risk. Whether risk is influenced by polymorphisms in other vitamin D metabolism genes and whether calcium or vitamin D intake modifies risk by genotype have not been evaluated.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm1</italic>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa1</italic>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq1</italic>
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok1</italic>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">baTL </italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAtS</italic>
###xml 335 342 335 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 412 414 412 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC</italic>
###xml 423 435 <span type="species:ncbi:9606">Participants</span>
We conducted a nested case-control study within the Cancer Prevention Study II Nutrition Cohort of associations between breast cancer and four VDR single-nucleotide polymorphisms (SNPs), Bsm1,Apa1,Taq1, and Fok1, a poly(A) microsatellite, and associated haplotypes (baTL and BAtS). We also examined one SNP in the 24-hydroxylase gene (CYP24A1) and two in the vitamin D-binding protein (group-specific component [GC]) gene. Participants completed a questionnaire on diet and medical history at baseline in 1992. This study includes 500 postmenopausal breast cancer cases and 500 controls matched by age, race/ethnicity, and date of blood collection.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm1 bb </italic>
###xml 242 245 240 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bb </italic>
###xml 248 251 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BB </italic>
###xml 356 357 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 357 369 355 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">interaction </sub>
###xml 417 422 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq1 </italic>
###xml 79 84 <span type="species:ncbi:9606">women</span>
###xml 227 232 <span type="species:ncbi:9606">women</span>
Incident breast cancer was not associated with any genotype examined. However, women with the Bsm1 bb SNP who consumed greater than the median intake of total calcium (>/=902 mg/day) had lower odds of breast cancer compared to women with the Bb or BB genotype and less than the median calcium intake (odds ratio 0.61, 95% confidence interval 0.38 to 0.96; pinteraction = 0.01). Similar interactions were observed for Taq1 (T allele) and the poly(A) (LL) repeat.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 187 192 <span type="species:ncbi:9606">women</span>
We found no overall association between selected vitamin D pathway genes and postmenopausal breast cancer risk. However, certain VDR gene polymorphisms were associated with lower risk in women consuming high levels of calcium, suggesting that dietary factors may modify associations by VDR genotype.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Vitamin D has been associated with a lower risk of several types of cancer, including breast cancer [1,2]. Its action is mediated through the vitamin D receptor (VDR), a nuclear transcription-regulating factor that signals the synthesis of proteins involved in bone mineral homeostasis and cell-cycle regulation [2]. The receptor is present in most cell types, including normal and neoplastic breast tissue [3]. Clinically, breast tumors with greater VDR expression relapse more slowly after first diagnosis [4].
###end p 11
###begin p 12
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq1</italic>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm1</italic>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa1</italic>
###xml 313 317 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm1</italic>
###xml 334 335 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 369 373 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa1</italic>
###xml 390 391 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 429 433 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq1</italic>
###xml 449 450 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 627 628 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 629 630 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 678 679 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 680 682 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 693 694 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 695 697 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 762 770 756 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm1 bb </italic>
###xml 863 865 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
The VDR gene contains several polymorphisms. Three single-nucleotide polymorphisms (SNPs) located near the 3' region have been examined in relation to breast cancer [2]. These polymorphisms, identified by their restriction endonuclease cleavage sites (Taq1,Bsm1, and Apa1), include an intronic G-->A replacement (Bsm1, rs1544410, G = b), an intronic C-->A replacement (Apa1, rs7975232, C = a), and a T-->C replacement in exon 9 (Taq1, rs731236, C = t), which result in a synonymous change at codon 352. Although not functional, these SNPs are strongly linked with a poly(A) microsatellite repeat in the 3' untranslated region [5,6] which may influence VDR mRNA stability. Five [7-11] of nine [7-15] studies reported higher breast cancer risk associated with the Bsm1 bb genotype. Other VDR 3' SNPs or haplotypes have been inconsistently related to breast cancer [16].
###end p 12
###begin p 13
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok1 f </italic>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ff </italic>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok1 </italic>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
The presence of the Fok1 f allele in the 5' promoter region of the VDR (rs2228570) results in production of a VDR protein that is three amino acids longer and less effective as a transcriptional activator [16]. The ff genotype was associated with a statistically significant 34% higher breast cancer risk in the Nurses' Health Study [15]. Previous smaller studies of Fok1 and breast cancer risk were null [7,13,17].
###end p 13
###begin p 14
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Gene-environment interactions may explain in part the inconsistencies in the association between VDR SNPs and breast cancer across studies. Dietary factors are known to impact the vitamin D endocrine system [18], and recent studies suggest that diet may also influence autocrine/paracrine vitamin D metabolism [19]. Few studies have examined interactions between dietary factors and VDR polymorphisms in relation to breast cancer risk. Furthermore, polymorphisms in other genes in the vitamin D metabolic pathway have not been examined in relation to breast cancer risk.
###end p 14
###begin p 15
###xml 150 152 150 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC</italic>
###xml 175 176 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 198 205 198 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 356 365 356 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a priori </italic>
###xml 296 301 <span type="species:ncbi:9606">women</span>
We examined several polymorphisms in the VDR gene, their associated haplotypes, and polymorphisms in the vitamin D-binding (group-specific component [GC]) protein and 1,25(OH)2D degradation enzyme (CYP24A1) genes in relation to breast cancer risk in a nested case-control study of postmenopausal women enrolled in a large prospective cohort. Of particular a priori interest was whether calcium and vitamin D intakes modified associations by genotype.
###end p 15
###begin title 16
Materials and methods
###end title 16
###begin title 17
Study population
###end title 17
###begin p 18
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 0 5 <span type="species:ncbi:9606">Women</span>
###xml 28 40 <span type="species:ncbi:9606">participants</span>
###xml 145 148 <span type="species:ncbi:9606">men</span>
###xml 153 158 <span type="species:ncbi:9606">women</span>
###xml 264 267 <span type="species:ncbi:9606">men</span>
###xml 279 284 <span type="species:ncbi:9606">women</span>
Women in this analysis were participants in the Cancer Prevention Study (CPS) II Nutrition Cohort, a prospective study of cancer incidence among men and women from 21 states in the US, established by the American Cancer Society in 1992 [20]. At enrollment, 86,404 men and 97,788 women completed a 10-page, self-administered questionnaire on medical, dietary, reproductive, and lifestyle variables. Beginning in 1997, follow-up questionnaires were sent to cohort members every 2 years to update exposure information and to ascertain newly diagnosed tumors.
###end p 18
###begin p 19
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 109 114 <span type="species:ncbi:9606">women</span>
From June 1998 through June 2001, blood specimens were collected from 21,965 Nutrition Cohort postmenopausal women. Using blood samples, we identified 502 breast cancer cases who were cancer-free in 1992. For each case, we randomly selected one postmenopausal female control who had provided a blood sample and was cancer-free (except non-melanoma skin cancer) at the time of the case's diagnosis [21]. Controls were individually matched to cases on birth date (+/- 6 months), race/ethnicity (Caucasian, African-American, Hispanic, Asian, other/unknown), and date of blood collection (+/- 6 months) using risk-set sampling. After excluding 2 cases with no match, 500 cases and 500 controls were available for analysis. All aspects of the CPS II cohort were approved by the Emory University (Atlanta, GA, USA) Institutional Review Board.
###end p 19
###begin title 20
Laboratory methods
###end title 20
###begin p 21
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok1</italic>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm1</italic>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa1</italic>
###xml 369 373 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq1</italic>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 525 527 525 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">14</sub>
###xml 529 531 529 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink">17</sub>
###xml 546 548 546 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink">18</sub>
###xml 550 552 550 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">22</sub>
###xml 174 186 <span type="species:ncbi:9606">participants</span>
Genotyping was performed at Applied Biosystems (ABI, Foster City, CA, USA) by laboratory personnel blinded to case-control status; blinded quality control samples for 10% of participants were inserted to validate genotyping procedures. TaqMan (ABI, Foster City, CA, USA) was used to distinguish alleles of the VDR gene at restriction enzyme sites Fok1, Bsm1, Apa1, and Taq1. A variable-length poly(A) sequence in the 3' untranslated region was assessed using methods previously described [6] and was classified as short (S, A14-A17) or long (L, A18-A22).
###end p 21
###begin p 22
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC </italic>
###xml 381 389 379 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 </italic>
###xml 471 472 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
We also genotyped selected SNPs in vitamin D pathway genes that were relatively common and validated at study inception. Using TaqMan, we genotyped a T432G aspartate to glutamate SNP (rs7041) and an A436C threonine to lysine SNP (rs4588), both in exon 11 of the GC gene, which codes for the vitamin D-binding protein (DBP). We also measured a synonymous A-->G SNP in exon 4 of the CYP24A1 gene (rs2296241), which encodes 24(OH)ase, which initiates degradation of 1,25(OH)2D.
###end p 22
###begin p 23
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm1 </italic>
###xml 183 185 183 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Concordance for quality control samples was 100%. The overall success rate for genotyping assays was at least 95%, except for Bsm1 (93%). All SNPs were in Hardy-Weinberg equilibrium (p >0.05).
###end p 23
###begin title 24
Dietary assessment
###end title 24
###begin p 25
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
Calcium, vitamin D, and dairy product intakes were measured in 1992 to 1993 [20] using a semi-quantitative 68-item food frequency questionnaire (FFQ), which is a modification of the brief 'Health Habits and History Questionnaire' developed by Block and colleagues [22]. Dietary and total nutrient intakes were estimated using the Diet Analysis System version 3.8a (Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD, USA) [23]. Total calcium estimates (mg/day) included contributions from diet, individual calcium supplements (250, 500, 600, or 750 mg per tablet), and multivitamin pills (estimated at 130 mg per multivitamin pill). Vitamin D values were added to the nutrient database using US Department of Agriculture sources [24]. Total intake of vitamin D (IU/day) was estimated from diet (fortified milk, cereals, and fish) and multivitamin usage (400 IU per pill). Nutrient estimates were adjusted for total energy using the residual method [25].
###end p 25
###begin p 26
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 319 321 319 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r </italic>
###xml 374 376 374 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r </italic>
###xml 146 158 <span type="species:ncbi:9606">participants</span>
###xml 282 287 <span type="species:ncbi:9606">women</span>
The FFQ was validated using four random 24-hour recalls collected throughout a 1-year period as the comparison measure among 441 Nutrition Cohort participants [26]. Median energy-adjusted, attenuation-corrected Pearson validity correlations and 95% confidence intervals (CIs) among women were high for dietary calcium (r = 0.66, 95% CI 0.51 to 0.76) and for dairy products (r = 0.63, 95% CI 0.45 to 0.77).
###end p 26
###begin title 27
Statistical analyses
###end title 27
###begin p 28
###xml 13 15 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 145 149 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm1</italic>
###xml 150 154 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa1</italic>
###xml 160 165 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq1 </italic>
###xml 284 286 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 570 572 568 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 583 591 581 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 592 594 590 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 647 655 645 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
We used a chi2 test to assess whether VDR, GC, and CYP24A1 genotype distributions were in Hardy-Weinberg equilibrium. Haplotypes of the VDR SNPs Bsm1,Apa1, and Taq1 and the poly(A) repeat were estimated using the expectation-maximization algorithm implemented in the TAGSNPS program [27]. To account for matching, conditional logistic regression was used to examine the association between all SNPs and the VDR haplotypes and postmenopausal breast cancer risk. We adjusted for additional risk factors and confounders as noted below. The main analysis combined invasive (n = 393) and in situ (n = 107) breast tumors; sensitivity analyses excluding in situ cases showed similar findings; thus, all cases are presented.
###end p 28
###begin p 29
Covariates included education, age at menopause and menarche, parity, age at first live birth, personal history of benign breast disease, family history of breast cancer in mother or sisters, postmenopausal hormone replacement therapy use, and body mass index. Adjustment for alcohol consumption did not change the effect estimates and was not included.
###end p 29
###begin p 30
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok1</italic>
###xml 468 470 468 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
We examined whether dietary or total calcium or vitamin D modified associations by genotype; interaction terms between genotypes and each dietary variable in continuous form were included in the conditional logistic regression models. Total energy intake was included in the models examining dietary interactions. Two-way interactions of the VDR haplotypes, Fok1, GC SNPs and the CYP24A1 SNP were examined. Statistical interaction was evaluated using the Wald test; a p value of less than 0.05 was considered statistically significant.
###end p 30
###begin title 31
Results
###end title 31
###begin p 32
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 271 273 271 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC</italic>
###xml 278 286 278 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 </italic>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">baTL </italic>
###xml 622 627 622 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAtS </italic>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bATL </italic>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">baTL </italic>
###xml 736 741 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAtS </italic>
###xml 778 783 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bATL </italic>
###xml 31 43 <span type="species:ncbi:9606">participants</span>
Descriptive characteristics of participants in this study are presented in Table 1. Cases and controls had a median age of 62 years (range 43 to 75 years) at enrollment in 1992, and 99% were Caucasian. None of the VDR genotypes or polymorphisms in the vitamin D-binding (GC) or CYP24A1 gene was significantly associated with overall postmenopausal breast cancer risk (Table 2). Heterozygote and homozygote variants for SNPs near the 3' end of the VDR gene were combined because of similar odds ratios (ORs). Three VDR haplotypes were identified that explained more than 96% of the variance among these SNPs: baTL (45.2%), BAtS (38.7%), and bATL (12.3%). Haplotype associations were similarly null: baTL OR = 0.89 (95% CI 0.66 to 1.20), BAtS OR = 1.24 (95% CI 0.92 to 1.66), and bATL OR = 0.96 (95% CI 0.69 to 1.32) for one or two copies versus none.
###end p 32
###begin p 33
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 284 287 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BB </italic>
###xml 290 298 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bb Bsm1 </italic>
###xml 385 388 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bb </italic>
###xml 436 437 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 437 449 437 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink">interaction </sub>
###xml 508 516 508 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq1 TT </italic>
###xml 762 765 762 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC </italic>
###xml 768 776 768 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 </italic>
###xml 1120 1124 1120 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok1</italic>
###xml 1184 1189 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok1 </italic>
###xml 212 217 <span type="species:ncbi:9606">women</span>
###xml 326 331 <span type="species:ncbi:9606">women</span>
In analyses stratified by dietary factors, total calcium intake (but not vitamin D intake) modified the associations between polymorphisms near the 3' end of the VDR and breast cancer risk (Table 3). Compared to women with less than median total calcium intakes (<902 mg/day) and the BB or Bb Bsm1 genotype (reference group), women with calcium intakes of more than 902 mg/day and the bb genotype had a 39% lower risk of breast cancer (pinteraction = 0.01). Similar findings were observed for those with the Taq1 TT and the poly(A) LL tail. These interactions were similar and statistically significant for dietary calcium, and no effect modification was observed with dietary vitamin D or dairy product consumption. Diet did not modify the associations between GC or CYP24A1 gene polymorphisms and breast cancer risk (not shown). We also observed no statistically significant effect modification in analyses stratified by median UV index for the state of residence as a proxy for cutaneous production of vitamin D. In addition, we observed no significant interactions between any two-way combination of VDR haplotypes, Fok1, or CYP24A1 or GC genotypes or in specific combinations of Fok1 and poly(A) genotypes.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 258 260 258 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bb</italic>
###xml 267 269 267 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TT</italic>
###xml 133 138 <span type="species:ncbi:9606">women</span>
###xml 149 154 <span type="species:ncbi:9606">women</span>
###xml 319 324 <span type="species:ncbi:9606">women</span>
None of the genotypes or haplotypes examined from the vitamin D pathway was associated with postmenopausal breast cancer risk in all women. However, women with a calcium intake higher than the median were at lower breast cancer risk if they had the VDR Bsm1 bb, Taq1 TT, or the poly(A) long repeat (LL) genotype. Among women with a calcium intake lower than the median, these VDR genotypes were not associated with lower breast cancer risk.
###end p 35
###begin p 36
###xml 36 44 36 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm1 bb </italic>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bb </italic>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">baT </italic>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 962 970 962 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BsmI BB </italic>
###xml 981 984 981 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bb </italic>
###xml 234 239 <span type="species:ncbi:9606">women</span>
###xml 400 405 <span type="species:ncbi:9606">women</span>
###xml 1065 1070 <span type="species:ncbi:9606">women</span>
The lack of association between the Bsm1 bb genotype or associated polymorphisms in the 3' region and breast cancer risk is in contrast to findings in five studies that reported increased risk of breast cancer, mostly among Caucasian women with the bb genotype [7-11]. Four other studies, plus ours, have not replicated this association [12-15]; two of these were in Hispanic [13] and Taiwanese [14] women. Other SNPs in the baT haplotype allele likewise have been inconsistently related to breast cancer risk [16]. It is unclear whether chance or underlying differences in the populations studied explain these inconsistencies. It is conceivable that differences in background risk factor profiles (menopausal status, reproductive factors, obesity, or dietary intake) contribute to these variations. Most of these studies included both pre- and postmenopausal cases; in the one study that presented results stratified by menopausal status [15], results for the BsmI BB versus the bb allele were similar for premenopausal (OR = 0.92) and postmenopausal (OR = 0.94) women.
###end p 36
###begin p 37
###xml 278 287 278 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 885 886 885 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 975 976 975 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 979 980 979 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1065 1073 1065 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BsmI bb </italic>
###xml 1182 1185 1182 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BB </italic>
###xml 1188 1191 1188 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bb </italic>
###xml 1201 1202 1201 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 597 603 <span type="species:ncbi:9606">humans</span>
###xml 1020 1025 <span type="species:ncbi:9606">women</span>
In our study, dietary calcium intake, but not vitamin D intake, significantly modified the association between VDR SNPs near the 3' end of the gene and breast cancer risk. Both nutrients have direct effects on cell proliferation and differentiation of several cancer cell lines in vitro [28,29]. In a rodent model, calcium reduces fat-induced cell proliferation by maintaining intracellular calcium concentrations [30]. It is plausible that polymorphisms in the VDR gene could modify the effects of exposures such as vitamin D or calcium on breast cancer risk, although the specific mechanisms in humans are unknown. Although vitamin D intake did not modify risk in our analysis, we did not measure plasma 25(OH)D, an integrated measure of vitamin D status from diet and UVB synthesis. Higher circulating levels of the storage form of vitamin D (25(OH)D) may lower breast cancer risk [9,31], potentially by providing substrate for breast tissue-specific synthesis of 1,25(OH)2D [3]. In one case-control study in the UK, women with low plasma 25(OH)D levels and the BsmI bb VDR genotype had a 6.8-fold higher risk of breast cancer than individuals with higher 25(OH)D levels and the BB or Bb genotype [9]. Thus, calcium or related nutrients may influence tissue-specific vitamin D metabolism in ways that are as yet unclear, possibly varying by VDR genotype. The interactions we observed may also be due to chance and should be replicated.
###end p 37
###begin p 38
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok1 ff </italic>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 344 351 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eagues </italic>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 413 418 <span type="species:ncbi:9606">women</span>
###xml 484 492 <span type="species:ncbi:9606">patients</span>
Our null findings for the Fok1 ff SNP and breast cancer risk do not replicate the positive association observed in the Nurses' Health Study [15] but do agree with those of three smaller studies [7,13,17], nor did we replicate previously reported potential interactions between different VDR polymorphisms observed by others [8,15]. Guy and colleagues [8] reported an approximately two-fold increase in risk among women with the FFLL or FfLL genotypes versus other combinations; among patients with metastases, the risk was three-fold greater. The mix of grade, lymph node involvement, or metastases in cases studied may also contribute to variability in findings across studies.
###end p 38
###begin p 39
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC </italic>
###xml 106 114 106 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 </italic>
###xml 252 254 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 266 274 266 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 </italic>
###xml 323 324 323 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
We observed no association with two non-synonymous polymorphisms in the GC gene (codes for DBP) or one in CYP24A1 and postmenopausal breast cancer. The polymorphic DBP facilitates vitamin D actions, and DBP alleles differ in their affinity for 1,25(OH)2 D [32]. The CYP24A1 gene codes for 24(OH)ase, which degrades 1,25(OH)2D. The potential for the SNPs we examined to alter DBP or CYP24A1 function is possible but has not been studied. Some studies have suggested a relationship of these SNPs with other outcomes, including asthma, glucose tolerance, and bone mineral density [33-35]. We are not aware of any studies that examined these SNPs in relation to breast cancer.
###end p 39
###begin p 40
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Limitations of this analysis include the use of a single assessment of diet, on average 6 years before diagnosis of breast cancer, which may have led to misclassification of dietary intake. We did not measure blood levels of 25(OH)D to assess vitamin D status. However, our FFQ was validated [26] and diet was assessed before cancer diagnosis. Larger case numbers would have provided greater statistical power to examine gene-gene and gene-diet interactions; however, this study is among the largest published to date for postmenopausal breast cancer.
###end p 40
###begin title 41
Conclusion
###end title 41
###begin p 42
###xml 100 102 100 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GC</italic>
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 </italic>
###xml 178 183 <span type="species:ncbi:9606">women</span>
Our research does not support an independent association between selected polymorphisms in the VDR, GC, or CYP24A1 genes and postmenopausal breast cancer risk among US Caucasian women. However, calcium intake appeared to modify the association of VDR SNPs with breast cancer risk. More research is needed to determine whether environmental factors, particularly diet, influence cancer risk by vitamin D pathway genotype.
###end p 42
###begin title 43
Abbreviations
###end title 43
###begin p 44
CI = confidence interval; CPS = Cancer Prevention Study; DBP = vitamin D-binding protein; FFQ = food frequency questionnaire; GC = group-specific component; OR = odds ratio; SNP = single-nucleotide polymorphism; VDR = vitamin D receptor.
###end p 44
###begin title 45
Competing interests
###end title 45
###begin p 46
The authors declare that they have no competing interests.
###end p 46
###begin title 47
Authors' contributions
###end title 47
###begin p 48
MLM conceived the study and drafted the manuscript. VLS, HSF, EEC, and RMB made substantial contributions to the conception and design of the study. MJT, CR and EEC made substantial contributions to the acquisition and interpretation of data. WRD conducted the statistical analyses. All authors were involved in revising the manuscript critically for important intellectual content. All authors read and approved the final manuscript.
###end p 48
###begin article-title 49
The epidemiology of vitamin D and cancer incidence and mortality: a review (United States)
###end article-title 49
###begin article-title 50
Vitamin D and breast cancer
###end article-title 50
###begin article-title 51
Autocrine metabolism of vitamin D in normal and malignant breast tissue
###end article-title 51
###begin article-title 52
Possible role for vitamin D in controlling breast cancer cell proliferation
###end article-title 52
###begin article-title 53
Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies
###end article-title 53
###begin article-title 54
Variants of the VDR gene and risk of colon cancer (United States)
###end article-title 54
###begin article-title 55
Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population
###end article-title 55
###begin article-title 56
Vitamin D receptor gene polymorphisms and breast cancer risk
###end article-title 56
###begin article-title 57
Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population
###end article-title 57
###begin article-title 58
Association of breast cancer with vitamin D receptor gene polymorphism (abstract)
###end article-title 58
###begin article-title 59
Vitamin D receptor gene polymorphism is associated with metastatic breast cancer
###end article-title 59
###begin article-title 60
Vitamin D receptor gene polymorphisms in breast cancer
###end article-title 60
###begin article-title 61
Vitamin D receptor genotype and breast cancer in Latinas (United States)
###end article-title 61
###begin article-title 62
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients
###end article-title 62
###begin article-title 63
Associations between polymorphisms in the vitamin D receptor and breast cancer risk
###end article-title 63
###begin article-title 64
Genetic vitamin D receptor polymorphisms and risk of disease
###end article-title 64
###begin article-title 65
Association of a vitamin D receptor polymorphism with sporadic breast cancer development
###end article-title 65
###begin article-title 66
Vitamin D
###end article-title 66
###begin article-title 67
Phystoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas
###end article-title 67
###begin article-title 68
The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics
###end article-title 68
###begin article-title 69
A reduced dietary questionnaire: development and validation
###end article-title 69
###begin article-title 70
US Department of Agriculture: Provisional Table On Vitamin D Content Of Foods
###end article-title 70
###begin article-title 71
Total energy intake: implications for epidemiologic analyses
###end article-title 71
###begin article-title 72
Validation of the American Cancer Society Cancer Prevention Study II Nutrition Survey Cohort Food Frequency Questionnaire
###end article-title 72
###begin article-title 73
Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals
###end article-title 73
###begin article-title 74
Vitamin D, calcium, and prevention of breast cancer: a review
###end article-title 74
###begin article-title 75
Calcium, vitamin D and colorectal cancer: a review of the epidemiologic evidence
###end article-title 75
###begin article-title 76
###xml 135 154 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
Effects of dietary fat, calcium, and vitamin D on growth and mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene in female Sprague-Dawley rats
###end article-title 76
###begin article-title 77
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer
###end article-title 77
###begin article-title 78
A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis
###end article-title 78
###begin article-title 79
###xml 85 90 <span type="species:ncbi:9606">human</span>
Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density
###end article-title 79
###begin article-title 80
Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway
###end article-title 80
###begin article-title 81
Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance
###end article-title 81
###begin title 82
Figures and Tables
###end title 82
###begin p 83
Selected characteristics of breast cancer cases and controls
###end p 83
###begin p 84
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 16 24 <span type="species:ncbi:9606">children</span>
###xml 43 48 <span type="species:ncbi:9606">women</span>
aMean number of children only among parous women.
###end p 84
###begin p 85
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
Associations between SNPs in VDR, GC, and CYP24A1 genes and postmenopausal breast cancer riska
###end p 85
###begin p 86
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
aAll models contain a variable for unknown SNP genotype which is not presented. bModels are adjusted for body mass index, history of breast cyst, hormone replacement therapy use, family history of breast cancer, education, parity and age at first birth combined, age at menarche, and age at menopause. CI, confidence interval; GC, group-specific component; OR, odds ratio; SNP, single-nucleotide polymorphism; VDR, vitamin D receptor.
###end p 86
###begin p 87
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
VDR genotype and postmenopausal breast cancer risk stratified by total calcium and vitamin D intakesa
###end p 87
###begin p 88
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 319 320 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
aMultivariate adjusted models contain the SNP, dietary exposure, and interaction term and adjust for body mass index, history of breast cyst, hormone replacement therapy use, family history of breast cancer, education, parity and age at first birth combined, age at menarche, age at menopause, and total energy intake. bInteraction terms were created using continuous form of dietary variables. CI, confidence interval; OR, odds ratio; SNP, single-nucleotide polymorphism; VDR, vitamin D receptor.
###end p 88

